Publications
Molecular Shielding of the Pan-Hematopoietic Marker CD45 May Enable a Targeted Universal Approach for Replacement of the Hematopoietic System
Data presented during a poster session at ASGCT on May 18, 2023, that describes key progress with shielded CD45 cells.
Engineered Single Amino Acid Substitutions Protect Hematopoietic Stem and Progenitor Cells From CD123 Targeted Immunotherapy
Data presented during a poster session at ASH on December 11, 2022, that describes key progress with shielded CD123 cells.
Function-Preserving Single Amino Acid Substitutions Shield Hematopoietic Stem and Progenitor Cells from CD117-Targeted Immunotherapy in Vivo
Data presented during a poster session at ASH on December 11, 2022, that describes key progress with shielded CD117 cells.